Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Inventory Average: 2019-2025

Historic Inventory Average for Sunshine Biopharma (SBFM) over the last 6 years, with Sep 2025 value amounting to $13.5 million.

  • Sunshine Biopharma's Inventory Average rose 47.90% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year increase of 47.90%. This contributed to the annual value of $8.5 million for FY2024, which is 88.51% up from last year.
  • Per Sunshine Biopharma's latest filing, its Inventory Average stood at $13.5 million for Q3 2025, which was up 8.87% from $12.4 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Inventory Average ranged from a high of $13.5 million in Q3 2025 and a low of $25,216 during Q1 2021.
  • Over the past 3 years, Sunshine Biopharma's median Inventory Average value was $8.1 million (recorded in 2024), while the average stood at $8.1 million.
  • Data for Sunshine Biopharma's Inventory Average shows a peak YoY surged of 2,337.76% (in 2023) over the last 5 years.
  • Sunshine Biopharma's Inventory Average (Quarterly) stood at $88,480 in 2021, then skyrocketed by 1,911.52% to $1.8 million in 2022, then spiked by 188.01% to $5.1 million in 2023, then spiked by 105.81% to $10.5 million in 2024, then surged by 47.90% to $13.5 million in 2025.
  • Its last three reported values are $13.5 million in Q3 2025, $12.4 million for Q2 2025, and $11.6 million during Q1 2025.